Grassin Delyle Stanislas, Duverneuil-Mayer Charlotte, Abe Emuri, Mathieu Bertille, Lorin De La Grandmaison Geoffroy, Charlier Philippe, Alvarez Jean Claude
Laboratory of Pharmacology and Toxicology, Raymond Poincaré Universitary Hospital, AP-HP, 104 Boulevard Raymond Poincaré, 92380 Garches, France.
Forensic Sci Int. 2008 Jul 4;178(2-3):e19-21. doi: 10.1016/j.forsciint.2008.03.003. Epub 2008 Apr 10.
The dead body of a 44-year-old woman, previously known for depression and alcoholism, has been discovered at her place of residence by her husband. A forensic autopsy has been carried out. The results indicated unspecific histological lesions (alveolar oedema, liver steatosis and interstitial nephritis) but did not reveal any apparent cause of death. Several boxes of medicines have been found near the body, justifying a toxicological analysis. This has been performed on peripheral blood and urine samples using liquid chromatography with diode array and mass spectrometric detections, in conjunction with gas chromatography coupled with mass spectrometry. Ethanol has been found (1.24 g/L in blood, 2.63 g/L in urine and 1.33 g/kg in gastric content), as well as therapeutic concentrations of meprobamate (14.1mg/L) and low concentrations of nordazepam (0.12 mg/L) in blood. On the other hand, particularly high levels of labetalol, a widely used beta-blocker, have been found both in blood (1.7 mg/L) and urine (20.2mg/L), which led us to measure labetalol levels in available viscera samples (liver, heart, kidney, and lung) and gastric content. Measured concentrations were 14.2 microg/g, 7.8 microg/g, 5.4 microg/g, 5.2 microg/g and 31.1 microg/g, respectively. We describe here the first report of a fatal intoxication attributed to labetalol that is linked to its acute toxicity, with tissue distribution of this beta-blocker.
一名44岁女性的尸体被其丈夫在住所发现,该女性此前患有抑郁症且酗酒。已进行法医尸检。结果显示有非特异性组织学病变(肺泡水肿、肝脂肪变性和间质性肾炎),但未发现明显死因。尸体附近发现了几盒药品,因此进行了毒理学分析。使用二极管阵列液相色谱和质谱检测,结合气相色谱-质谱联用技术,对外周血和尿液样本进行了分析。血液中检测到乙醇(1.24 g/L)、尿液中乙醇含量为2.63 g/L、胃内容物中乙醇含量为1.33 g/kg,血液中还检测到了治疗浓度的甲丙氨酯(14.1mg/L)和低浓度的去甲西泮(0.12 mg/L)。另一方面,在血液(1.7 mg/L)和尿液(20.2mg/L)中均发现了特别高浓度的拉贝洛尔,拉贝洛尔是一种广泛使用的β受体阻滞剂,这促使我们测量了肝脏、心脏、肾脏、肺等可用内脏样本以及胃内容物中的拉贝洛尔水平。测量浓度分别为14.2微克/克、7.8微克/克、5.4微克/克、5.2微克/克和31.1微克/克。我们在此报告首例因拉贝洛尔导致的致命中毒事件,该事件与其急性毒性有关,并描述了这种β受体阻滞剂的组织分布情况。